Mental Health & Psychiatry Clinical Trials Update: Week 26, 2026

Published June 26, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

Smartphones for Opiate Addiction Recovery

This Phase 3 trial from NYU Langone Health is testing a smartphone app designed to help people with opioid-use disorder reduce the reuse of illicit opioids. If this app proves effective, it could become a widely accessible tool to support individuals in recovery, offering additional help between clinical visits. The study is recruiting adults in the United States who are working to overcome opioid addiction.

Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children

Sponsored by Khyber Medical University Peshawar, this trial explores whether neuroplasticity-targeted supplements can improve symptoms in children aged 6 to 12 with ADHD. The study also looks at changes in brain markers related to inflammation, which may help explain how these supplements work. If successful, this approach could provide a new, supplement-based treatment option that might manage ADHD symptoms with fewer side effects. The trial is currently recruiting in Pakistan and will last 12 weeks.

Digital Coach to Support Exposure Therapy Homework for Anxious Youth

Massachusetts General Hospital is testing BraveBot, a digital coaching tool to help young people aged 12 to 22 with anxiety and obsessive-compulsive disorder complete their exposure therapy homework. This support could make therapy easier to follow and more effective, helping youth feel more confident in managing their symptoms. The study is recruiting participants from outpatient clinics.

Dog-Assisted Therapy in Adolescents Attending a Child and Adolescent Mental Health Day Hospital

This completed study from the Hospital Clinic of Barcelona examined the addition of dog-assisted therapy to usual treatment for adolescents with mental health disorders. The therapy aimed to improve emotional regulation and engagement in treatment for young patients aged 12 to 18. If shown to be effective, this approach may offer a comforting and supportive therapy option for adolescents facing mental health challenges.

Internet-delivered Parent-Child Interaction for Parents of Children 2-7 Years With Disruptive Behaviors

Karolinska Institutet tested an online Parent-Child Interaction Therapy program for parents of young children with disruptive behaviors. Delivered entirely online over 10 weeks, this program could make effective behavioral support more accessible by removing the need for in-person visits. The study involved 21 participants in Sweden and focused on improving child behavior and strengthening parent-child relationships.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.